Decentralized Clinical Trials & Health Equity
- Clinical trial participation enhances health outcomes, but access disparities persist for regional, rural, and socially disadvantaged populations.
- Food and Drug Administration (FDA) has issued guidelines to integrate various elements of the DCT system into standard practice.
- With continued implementation of FDA guidelines and expansion of telehealth infrastructure, decentralized clinical trials promise to further democratize access to vital healthcare research opportunities for all populations.
Decentralized clinical trials (DCTs) are revolutionizing healthcare access, especially for underserved communities, by bringing clinical trials directly to them. This innovative approach, highlighted in the latest discussions, is key to health equity, improving outcomes and broadening participation. News Directory 3 recently reported on how the FDA is guiding the integration of DCT systems into standard practices. Telehealth plays a crucial role in networked DCTs, connecting primary care with satellite sites, thereby expanding research reach. Learn how DCTs are democratizing access to vital healthcare research opportunities. Discover what’s next for this vital healthcare evolution.
Decentralized Clinical Trials Improve Access to Healthcare
Updated May 26, 2025
Clinical trial participation enhances health outcomes, but access disparities persist for regional, rural, and socially disadvantaged populations. decentralized clinical trials (DCTs) are emerging as a solution to bridge this gap, offering improved access to clinical trials for underserved communities.
The U.S. Food and Drug Administration (FDA) has issued guidelines to integrate various elements of the DCT system into standard practice. These guidelines emphasize the role of telehealth in connecting primary and satellite sites, thereby creating networked systems that extend the reach of clinical research.
What’s next
With continued implementation of FDA guidelines and expansion of telehealth infrastructure, decentralized clinical trials promise to further democratize access to vital healthcare research opportunities for all populations.